Revision to Prior Period Financial Statements (Tables)

7 Months Ended

Dec. 31, 2020

Accounting Changes And Error Correction [Abstract]

Schedule of Balance Sheet and the misstatement

	As of December 17, 2020
	As Previously Reported			Restatement Adjustment			As Restated
Balance Sheet
Total assets	$	59,328,581		$	-		$	59,328,581
Liabilities and stockholders’ equity
Total current liabilities	$	198,291		$	-		$	198,291
Deferred underwriting commissions		2,012,500						2,012,500
Derivative warrant liabilities		-			15,776,805			15,776,805
Total liabilities		2,210,791			15,776,805			17,987,596
Class A common stock, $0.0001 par value; shares subject to possible redemption		52,117,783			(15,776,805	)		36,340,978
Stockholders’ equity
Preferred stock- $0.0001 par value		-			-			-
Class A common stock - $0.0001 par value		69			148			217
Class B common stock - $0.0001 par value		144			-			144
Additional paid-in-capital		5,147,829			3,570,433			8,718,262
Accumulated deficit		(148,035	)		(3,570,581	)		(3,718,616	)
Total stockholders’ equity		5,000,007			-			5,000,007
Total liabilities and stockholders’ equity	$	59,328,581		$	-		$	59,328,581